Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CYP4F2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DCAF15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF384 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TXK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WFDC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WIPF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAPBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXW12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OTUD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLR3C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDM16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1109 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930107 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR3150B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on